<ѻýҕl>New Option OK'd for Pompe Diseaseѻýҕl> FDA approves two-component therapy for patients not improving on enzyme replacement therapy Sep 29, 2023
<ѻýҕl>Dianne Feinstein Dies; Prison for Alzheimer's Fraudsters; Kaiser Strike Loomingѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Sep 29, 2023
<ѻýҕl>FDA Relents, Approves Novel Antidepressant After Many Rejectionsѻýҕl> Gepirone extended-release approved after nearly 2 decades of trying Sep 28, 2023
<ѻýҕl>OSHA Comes in for Both Praise and Harsh Criticism at House Hearingѻýҕl> Illinois lawmaker calls agency head "inept" during discussion of COVID vaccine mandate rule Sep 28, 2023
<ѻýҕl>FDA Adds Intestinal Blockage Reports to Ozempic Labelingѻýҕl> Joins other approved GLP-1 receptor agonists in noting the potential adverse reaction Sep 28, 2023
<ѻýҕl>Obamacare Makes Surprise Cameo in Second GOP Debateѻýҕl> Fentanyl crisis, transgender care, and abortion also got some air time Sep 28, 2023
<ѻýҕl>FDA Panel Overwhelmingly Rejects ALS Cell Therapyѻýҕl> Echoing concerns from agency reviewers, advisors can't find evidence of efficacy Sep 28, 2023
<ѻýҕl>With Shutdown Likely, Policy Experts Weigh Health Risksѻýҕl> Food safety, innovation, and community health centers all could see trickle-down effects Sep 28, 2023
<ѻýҕl>FDA Displeased With Companies Purposely Adding Sesame to More Foodsѻýҕl> Agency issues updated guidance for limiting cross-contamination in wake of FASTER act Sep 27, 2023
<ѻýҕl>Mydriasis-Reversing Eye Drops Win FDA Approvalѻýҕl> Pupil diameter normalized significantly faster with phentolamine solution in phase III trials Sep 27, 2023
<ѻýҕl>States Face Challenges With Medicaid and CHIP 'Redeterminations'ѻýҕl> CMS officials flag problem with states' auto-renewal systems Sep 27, 2023
<ѻýҕl>Preventing Biden's Stumbles; Bruce Willis Aware of His Dementia? ABIM Prez to Retireѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Sep 27, 2023
<ѻýҕl>FTC Sues Anesthesia Group and Its Private Equity Backersѻýҕl> Companies accused of extracting "monopoly profits" while growing "monopoly power" Sep 26, 2023
<ѻýҕl>COVID Drug and New Mutations; Costco Offers $29 Care; Trump Unmasked Over Bronzerѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Sep 26, 2023
<ѻýҕl>FDA Staff Voice Serious Concerns About Investigational ALS Cell Therapyѻýҕl> Data are "scientifically incomplete" and manufacturing info is "grossly deficient" Sep 25, 2023
<ѻýҕl>Two Large Medical Groups Shun Medicare Advantage Plansѻýҕl> San Diego doctor groups latest to withdraw, citing low pay, prior authorization problems Sep 25, 2023
<ѻýҕl>White House Opens Gun Violence Prevention Officeѻýҕl> "We have to act, and we have to act now," says President Biden Sep 22, 2023
<ѻýҕl>The White House Cancer Moonshot Is a Dudѻýҕl> We're failing to take simple steps to reduce one of the biggest causes of cancer Sep 22, 2023
<ѻýҕl>FDA Panel: All Thumbs Down for GLP-1 Agonist Implant for Diabetesѻýҕl> We haven't seen "the best version of this device," said panel member Sep 22, 2023
<ѻýҕl>Flawed Rules in No Surprises Act Hurt Doctors and Patients, Experts Sayѻýҕl> Some practices are fighting to keep afloat, while patients are losing access to care Sep 21, 2023
<ѻýҕl>Medicare Advantage Ads Should Look Different This Yearѻýҕl> KFF examines past predatory ads as new CMS regulation goes into effect Sep 21, 2023
<ѻýҕl>FDA Advisors Grapple With Logistical, Ethical Issues of Artificial Womb Technologyѻýҕl> Further discussion about first-in-human trials is ongoing Sep 20, 2023
<ѻýҕl>FDA Shoots Down Needle-Free EpiPen Alternative, Requests More Dataѻýҕl> Agency asks drugmaker for a repeat-dose study before approval Sep 20, 2023
<ѻýҕl>Third Time's a Charm for GLP-1 Diabetes Device? FDA Staff Suggest Otherwise.ѻýҕl> Advisory committee to weigh in on safety concerns with GLP-1 receptor agonist implant Sep 20, 2023
<ѻýҕl>Large Study Eases Fears Over Zantac-Cancer Linkѻýҕl> In multinational cohort, cancer incidence with pulled drug no different than other H2RAs Sep 19, 2023
<ѻýҕl>Want Better Health Outcomes? Check Out What Other Countries Doѻýҕl> Countries who outperform the U.S. system have three things in common, expert says Sep 19, 2023
<ѻýҕl>FDA Approves JAK Inhibitor That Addresses Anemia in Myelofibrosisѻýҕl> In a phase III trial, momelotinib reduced anemia, constitutional symptoms, and splenomegaly Sep 18, 2023
<ѻýҕl>Trump: 6-Week Abortion Ban a 'Mistake'; Capitol Doc Scrutiny; Immigrant Health Costsѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Sep 18, 2023
<ѻýҕl>FDA Reviewers Have Concerns About Artificial Womb Trials in Humansѻýҕl> The Pediatric Advisory Committee will discuss if data support a safe first-in-human trial Sep 15, 2023
<ѻýҕl>No 'Silver Bullet' for Generic Drug Shortage, House Members Toldѻýҕl> A total of 301 drugs were in active shortage last year Sep 14, 2023
<ѻýҕl>A 'SAD' Story: Patient Stuck With $176K Bill After Medicare Policy Switchѻýҕl> CMS abruptly decided patients can self-administer Stelara -- even those with Parkinson's Sep 14, 2023
<ѻýҕl>Drug Companies, Allies Fight Back on Medicare Drug Price Negotiationsѻýҕl> They argue that the government is using coercion while claiming sellers have options Sep 14, 2023
<ѻýҕl>FDA Panel Reluctantly Backs Patisiran for ATTR Cardiomyopathyѻýҕl> Clinical meaningfulness is a different question, however Sep 13, 2023
<ѻýҕl>What It Will Really Take to Restore Trust in the CDCѻýҕl> A singular narrative, consistency, and relatability are paramount Sep 13, 2023
<ѻýҕl>FDA Warns Companies About Unapproved Ophthalmic Productsѻýҕl> Walgreens and CVS among companies accused of marketing products with "heightened risk of harm" Sep 13, 2023
<ѻýҕl>California Misinfo Law Is Destined for the Dustbinѻýҕl> Amendment repeals language, but licensing boards apparently had authority all along Sep 13, 2023
<ѻýҕl>FDA Panel Favors Dropping OTC Decongestantѻýҕl> Unanimous vote that the drug is ineffective Sep 12, 2023
<ѻýҕl>DEA Gets an Earful About Telehealth Prescribing of Controlled Substancesѻýҕl> Proposed in-person visit requirements raises concern for psychiatry groups Sep 12, 2023
<ѻýҕl>Novel System Snags FDA Approval for Severe Peripheral Arterial Diseaseѻýҕl> Device designed to prevent amputation in chronic limb-threatening ischemia Sep 12, 2023
<ѻýҕl>Stem-Cell Mobilization Booster Wins FDA Approval for Multiple Myelomaѻýҕl> Motixafortide plus filgrastim increased adequate harvest rate from 9.5% to 67.5% Sep 11, 2023